These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23536344)

  • 1. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
    Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
    Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
    World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
    Liang YM; Li XH; Li WM; Lu YY
    World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less.
    Kim MY; Park YS; Choi KD; Lee JH; Choi KS; Kim DH; Song HJ; Lee GH; Jung HY; Kim JH; Yun SC; Kim KC; Yook JH; Oh ST; Kim BS; Ryu MH; Kang YK
    J Clin Gastroenterol; 2012 Feb; 46(2):130-7. PubMed ID: 21617541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal gastrointestinal stromal tumor: clinical, pathologic, immunohistochemical characteristics, and surgical prognosis.
    Yang WL; Yu JR; Wu YJ; Zhu KK; Ding W; Gao Y; Shen QY; Lv KZ; Zhang Q; Yang XJ
    J Surg Oncol; 2009 Dec; 100(7):606-10. PubMed ID: 19697360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
    Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
    BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors.
    Orita H; Ito T; Kushida T; Sakurada M; Maekawa H; Wada R; Suehara Y; Kubota D; Sato K
    Biomed Res Int; 2014; 2014():651935. PubMed ID: 24977158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).
    Artigiani Neto R; Logullo AF; Stávale JN; Lourenço LG
    Acta Cir Bras; 2012 May; 27(5):315-21. PubMed ID: 22666745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
    Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
    Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence.
    Ziaran S; Harsanyi S; Bevizova K; Varchulova Novakova Z; Trebaticky B; Bujdak P; Galbavy S; Danisovic L
    Eur J Histochem; 2020 Mar; 64(2):. PubMed ID: 32214283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.